Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether administration of Arginine Butyrate +
ganciclovir/valganciclovir for up to three 21-day cycles is tolerable, and results in partial
or complete responses in patients with EBV(+) lymphoid malignancies.